Targeted Deletion of FGL-2/Fibroleukin in the Donor Modulates Immunologic Response and Acute Vascular Rejection in Cardiac Xenografts
Circulation - United States
doi 10.1161/circulationaha.105.534271
Full Text
Open PDFAbstract
Available in full text
Date
July 12, 2005
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)